Monthly archives for January, 2023
| Dolly Khanna is invested in Nitin Spinners. ICICI Direct has recommended a buy for the target price of Rs 290 (41% upside) | |
| Company: | Nitin Spinners |
| Brokerage: | ICICI-Direct |
| Date of report: | January 5, 2023 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 41% |
| Summary: | Consistent improvement in financial performance of NSL in spite of cyclical nature of textile industry signifies NSL’s ability of optimum asset utilisation leading to sustainable profit growth. In line with its superior fundamental performance, the stock price has grown at 15% CAGR over last five years |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Nano Nivesh, Nitin Spinners |
| CanFin Homes is in sweet spot. Buy for target price of Rs 625: ICICI Direct | |
| Company: | Can Fin Homes |
| Brokerage: | ICICI-Direct |
| Date of report: | January 2, 2023 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 17% |
| Summary: | Consistent business growth with focus on efficient operations coupled with relatively lower cost and strong underwriting to benefit earnings and return ratios |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Can Fin Homes, ICICI-Direct |
| Buy Gujarat Themis Biosyn for target price of Rs 909: HDFC Securities | |
| Company: | Gujarat Themis Biosyn |
| Brokerage: | HDFC Sec |
| Date of report: | January 2, 2023 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 17% |
| Summary: | Prior to FY20, company was engaged in contract manufacturing of Rifamycin S for Lupin. During FY20, management decided to change business model from contract manufacturing to manufacturing and sales model; as a result the company’s operating profitability has significantly improved. Company had reported robust numbers over FY20-22 |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Gujarat Themis Biosyn, HDFC Sec |
| Right time to check-in Chalet Hotels. Buy for target price of Rs 455 (37% Upside): PL | |
| Company: | Chalet Hotels |
| Brokerage: | Prabhudas Lilladher |
| Date of report: | December 27, 2022 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 37% |
| Summary: | We initiate coverage on Chalet Hotels Ltd (Chalet) with a ‘BUY’ rating, as it is a play on expected recovery in business travel complemented by an exposure to annuity business (18% share by FY25E) that acts as a hedge to deeply cyclical hospitality industry. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Chalet Hotels, Prabhudas Lilladher |
| Nifty Target for 2023 is 21500 (19% Upside) + Top 9 stocks to buy for 2023 with 35% gain: ICICI Direct | |
| Company: | Model Portfolio |
| Brokerage: | ICICI-Direct |
| Date of report: | December 27, 2022 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 35% |
| Summary: | Introducing FY25E and rolling over our valuations, we now value the Nifty at 21,500 i.e. 21x P/E on FY24-25E average EPS of Rs 1020 with corresponding Sensex target at 71,600; offering a healthy potential upside of ~19%. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |